Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Alcidion Group’s latest analyst update comes with no change to the existing price target, which can be just as informative as a move up or down. With no new analyst commentary released alongside this update, the focus shifts to what investors can track next to stay on top of how sentiment around the stock evolves. Read on to see how to monitor future revisions so you can follow the story as it develops. Stay updated as the Fair Value for Alcidion Group shifts by adding it to your watchlist or...
The Australian stock market is experiencing a cautious phase, influenced by high U.S. bond yields and concerns over rising price pressures in the economy, as noted by the RBA assistant governor. In such a climate, investors often seek opportunities that offer potential growth at lower price points, making penny stocks an intriguing option despite their somewhat outdated name. These stocks can represent smaller or newer companies with strong financial foundations, offering unique chances for...
Alcidion Group’s fair value estimate is set at A$0.14 and remains unchanged in the latest update, even as underlying model inputs have been fine tuned. That stability lines up with recent sector research, where analysts often adjust discount rates and growth assumptions while keeping a steady view on valuation when product roadmaps, guidance and cash generation frameworks look consistent. Read on to see what is driving this refreshed narrative and how you can track the key signposts from...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.